Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00181181 · ClinicalTrials.gov registry record · Phase 4

The Effect of Statin Use on Vascular Function in Hypertensive Subjects

A Phase 4 study, sponsored by Johns Hopkins University.

Terminated
Registry status
Phase 4
Development phase
24
Enrollment target

NCT00181181: Clinical Trial Phase 4 study, sponsored by Johns Hopkins University.

NCT00181181 is a Phase 4 study that was terminated before completion, run by Johns Hopkins University. The registered enrollment target is 24 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT00181181, a Phase 4 study, was terminated before completion, sponsored by Johns Hopkins University.

TERMINATED
Registry status
Phase 4
Development phase
24 participants
Enrollment target

Study Summary

This research is being done to find if treatment with atorvastatin, a drug that reduces cholesterol, improves the function of blood vessels among people with high blood pressure. Adults with mildly high blood pressure, or who are taking medication for high blood pressure but are otherwise healthy may join, with the approval of their health care provider. The study period is 14-17 weeks. Approximately 50 to 60 subjects will take part in the study.

Primary Outcome

microvascular function by echo doppler of coronary flow

Interventions

  • OTHER placebo
  • DRUG atorvastatin

Trial Details

FieldValue
Enrollment Target 24 participants
Start Date 2003-05
Est. Completion 2007-04
Phase Phase 4
Johns Hopkins University

1,448 total trials

Why NCT00181181 stopped before completion

NCT00181181 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 24 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (95% lower).

The record links to 0 conditions, and to 2 interventions - of which placebo is the first listed.

NCT00181181 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00181181 about?

NCT00181181 is a clinical study titled "The Effect of Statin Use on Vascular Function in Hypertensive Subjects". This research is being done to find if treatment with atorvastatin, a drug that reduces cholesterol, improves the function of blood vessels among people with high blood pressure. Adults with mildly high blood pressure, or who are taking medication for high blood pressure but are otherwise healthy ma...

What is the current status of trial NCT00181181?

This trial is currently terminated. It is a Phase 4 study. The enrollment target is 24 participants. The study started on 2003-05. Estimated completion is 2007-04.

What interventions are being tested in trial NCT00181181?

The interventions under investigation include: placebo (OTHER), atorvastatin (DRUG).

Who is sponsoring clinical trial NCT00181181?

This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00181181's enrollment target sits among peer trials

24 1699th of 2000 higher than 276 of 2,000 other Phase 4 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02331979 · 24 participants · NA

    Improving Bladder Function in SCI by Neuromodulation

  • NCT03096197 · 24 participants · NA

    Exoskeleton and Spinal Cord Stimulation for SCI

  • NCT03223922 · 24 participants · NA

    Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases

  • NCT03326921 · 24 participants · Phase 1

    HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00181181, the US trial registry maintained by the National Library of Medicine. NCT00181181 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.